OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From bench to bedside: Single-cell analysis for cancer immunotherapy
Emily F. Davis-Marcisak, Atul Deshpande, Genevieve Stein-O’Brien, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1062-1080
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
Aiping Zhang, Kai Miao, Heng Sun, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 3019-3033
Open Access | Times Cited: 155

Mechanisms driving the immunoregulatory function of cancer cells
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 148

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
Keyu Li, Joseph A. Tandurella, Jessica Gai, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1374-1391.e7
Open Access | Times Cited: 97

The changing role of natural killer cells in cancer metastasis
Isaac S. Chan, Andrew J. Ewald
Journal of Clinical Investigation (2022) Vol. 132, Iss. 6
Open Access | Times Cited: 72

A Review of Single-Cell RNA-Seq Annotation, Integration, and Cell–Cell Communication
Changde Cheng, Wenan Chen, Hongjian Jin, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1970-1970
Open Access | Times Cited: 70

Advancing CAR T cell therapy through the use of multidimensional omics data
Jingwen Yang, Yamei Chen, Ying Jing, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 211-228
Closed Access | Times Cited: 66

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
Zhewen Xiong, Stephen L. Chan, Jingying Zhou, et al.
Gut (2023) Vol. 72, Iss. 9, pp. 1758-1773
Open Access | Times Cited: 59

Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance
Hussein Sabit, Borros Arneth, Timothy M. Pawlik, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 75-75
Open Access | Times Cited: 6

Cancer immunotherapy in progress—an overview of the past 130 years
Hiroaki Ikeda
International Immunology (2025)
Closed Access | Times Cited: 2

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
Myung‐Chul Kim, Jin Zeng, Ryan Kolb, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5856-5856
Open Access | Times Cited: 59

Single cell RNA‐sequencing: A powerful yet still challenging technology to study cellular heterogeneity
May Sin Ke, Badran Elshenawy, Helen Sheldon, et al.
BioEssays (2022) Vol. 44, Iss. 11
Open Access | Times Cited: 51

Transcriptional vulnerabilities of striatal neurons in human and rodent models of Huntington’s disease
A. Matsushima, S. Sebastian Pineda, Jill R. Crittenden, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40

Spatial metabolomics reveals glycogen as an actionable target for pulmonary fibrosis
Lindsey R. Conroy, Harrison A. Clarke, Derek B. Allison, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 38

Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces
Atul Deshpande, Melanie Loth, Dimitrios N. Sidiropoulos, et al.
Cell Systems (2023) Vol. 14, Iss. 4, pp. 285-301.e4
Open Access | Times Cited: 24

Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors
Itay Tirosh, Mario L. Suvà
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1497-1506
Closed Access | Times Cited: 16

PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration
Alexander T.F. Bell, Jacob T. Mitchell, Ashley Kiemen, et al.
Cell Systems (2024) Vol. 15, Iss. 8, pp. 753-769.e5
Closed Access | Times Cited: 13

Virtual cells for predictive immunotherapy
Daniel Bergman, Elana J. Fertig
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 464-465
Closed Access | Times Cited: 1

Contribution of adaptive immunity to human COPD and experimental models of emphysema
Farrah Kheradmand, Yun Zhang, David B. Corry
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1059-1093
Closed Access | Times Cited: 33

Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma
Zhicheng Zhou, Mei-Ju May Chen, Yikai Luo, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1324-1340.e8
Open Access | Times Cited: 31

Cancer-on-chip: a 3D model for the study of the tumor microenvironment
Elisa Cauli, Michela Anna Polidoro, Simona Marzorati, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 22

Role of Th17 cells, Treg cells, and Th17/Treg imbalance in immune homeostasis disorders in patients with chronic obstructive pulmonary disease
Ru Ma, Hongling Su, Keping Jiao, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 20

SingPro: a knowledge base providing single-cell proteomic data
Xichen Lian, Yintao Zhang, Ying Zhou, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D552-D561
Open Access | Times Cited: 19

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 21, pp. 4408-4418
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top